INS and type 2 diabetes mellitus: Clinically, GFAT activity is increased in muscle biopsies obtained from insulin resistant patients with type II diabetes [105], while insulin resistance is improved markedly by insulin treatment in patients with severely insulin resistant, uncontrolled, obese, type II diabetes, concomitant with 40% increase in the levels of UDP-GlcNAc in muscle [106].